Abvc Biopharma (ABVC) Operating Leases (2019 - 2025)
Historic Operating Leases for Abvc Biopharma (ABVC) over the last 7 years, with Q3 2025 value amounting to $164072.0.
- Abvc Biopharma's Operating Leases rose 1538.03% to $164072.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $164072.0, marking a year-over-year increase of 1538.03%. This contributed to the annual value of $236807.0 for FY2024, which is 4188.17% down from last year.
- Abvc Biopharma's Operating Leases amounted to $164072.0 in Q3 2025, which was up 1538.03% from $177133.0 recorded in Q2 2025.
- Over the past 5 years, Abvc Biopharma's Operating Leases peaked at $1.4 million during Q1 2021, and registered a low of $142201.0 during Q3 2024.
- In the last 5 years, Abvc Biopharma's Operating Leases had a median value of $708022.0 in 2024 and averaged $689848.8.
- In the last 5 years, Abvc Biopharma's Operating Leases skyrocketed by 65104.31% in 2021 and then crashed by 7641.53% in 2025.
- Quarter analysis of 5 years shows Abvc Biopharma's Operating Leases stood at $1.1 million in 2021, then dropped by 29.6% to $791827.0 in 2022, then plummeted by 48.54% to $407457.0 in 2023, then tumbled by 41.88% to $236807.0 in 2024, then plummeted by 30.71% to $164072.0 in 2025.
- Its Operating Leases was $164072.0 in Q3 2025, compared to $177133.0 in Q2 2025 and $166985.0 in Q1 2025.